Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

Magnes, Teresa

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy. [electronic resource] - PloS one 2017 - e0180995 p. digital

Publication Type: Journal Article

1932-6203

10.1371/journal.pone.0180995 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--analysis
C-Reactive Protein--metabolism
Carcinoma, Squamous Cell--diagnosis
Cetuximab--therapeutic use
Female
Head and Neck Neoplasms--diagnosis
Humans
Leukocyte Count
Male
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Prognosis
Research Design
Retrospective Studies
Squamous Cell Carcinoma of Head and Neck
Survival Analysis
Time Factors